Alere initiates voluntary recall of the of the Alere INRatio2 PT/INR Strips Alere has initiated a voluntary Class 1 recall in the U.S. of the Alere INRatio2 PT/INR Professional Test Strips. This action is a result of complaints of patients who had a therapeutic or near therapeutic INR with the Alere INRatio2 PT/INR Professional Test Strip but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory. Alere has received nine serious adverse event reports, three of which described bleeding associated with patient deaths. The reason for the adverse event reports was significantly different test results between the Alere INRatio2 PT/INR Professional Test Strip and the local laboratory plasma INR test. The root cause for this issue has not yet been determined; therefore Alere cannot determine the patient conditions or circumstances that may contribute to the discrepancy.
On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: Alere (ALR) upgraded to Neutral from Sell at Goldman... Canadian National (CNI) upgraded to Outperform from Market Perform at Cowen... Charles Schwab (SCHW) upgraded to Overweight from Underweight at Barclays... Con-way (CNW) upgraded at Stifel... Dr Pepper Snapple (DPS) upgraded to Buy from Hold at Stifel... Francesca's (FRAN) upgraded to Neutral from Sell at Goldman... GoPro (GPRO) upgraded to Outperform from Neutral at RW Baird... PartnerRe (PRE) upgraded to Outperform from Market Perform at BMO Capital... Rice Energy (RICE) upgraded to Overweight from Equalweight at Capital One... Saia, Inc. (SAIA) upgraded at Stifel... Sibanye Gold (SBGL) upgraded to Outperformer from Sector Performer at CIBC.